Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure
Hansoh BioMedical R&D Company
Hansoh BioMedical R&D Company
GlaxoSmithKline
PharmaMar
Advenchen Laboratories, LLC
Takara Bio Inc.
Deciphera Pharmaceuticals, LLC
Cogent Biosciences, Inc.
Boehringer Ingelheim
Deciphera Pharmaceuticals, LLC
Intensity Therapeutics, Inc.
Polaris Group
Eli Lilly and Company
SpringWorks Therapeutics, Inc.
Rain Oncology Inc
Ascentage Pharma Group Inc.
Boehringer Ingelheim
ImmunityBio, Inc.
Philogen S.p.A.
Jiangsu HengRui Medicine Co., Ltd.
Eisai Inc.
AbbVie
Gradalis, Inc.
AB Science
Deciphera Pharmaceuticals, LLC
Amgen
Blueprint Medicines Corporation
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Bayer
Arog Pharmaceuticals, Inc.
AB Science
Tracon Pharmaceuticals Inc.
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Xian-Janssen Pharmaceutical Ltd.
Celldex Therapeutics
Hoffmann-La Roche
Hoffmann-La Roche
Novartis
Hoffmann-La Roche
Janssen Research & Development, LLC
Novartis
Threshold Pharmaceuticals
Hoffmann-La Roche
Sanofi
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Pfizer
Merck Sharp & Dohme LLC
Novartis
INSYS Therapeutics Inc
GlaxoSmithKline
Alaunos Therapeutics